These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8224101)

  • 21. Effects of drugs affecting the noradrenergic system on convulsions in the quaking mouse.
    Chermat R; Doaré L; Lachapelle F; Simon P
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Dec; 318(2):94-9. PubMed ID: 6276790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Participation of serotonin in development of morphine dependence in mice and rats.
    Kruszewska A
    Pol J Pharmacol Pharm; 1980; 32(5):655-63. PubMed ID: 6973754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of imipramine-induced seizures in amygdala-kindled rats.
    Ago J; Ishikawa T; Matsumoto N; Ashequr Rahman M; Kamei C
    Epilepsy Res; 2006 Nov; 72(1):1-9. PubMed ID: 16914292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonidine antinociceptive activity: effects of drugs influencing central monoaminergic and cholinergic mechanisms in the rat.
    Paalzow G; Paalzow L
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):119-26. PubMed ID: 133292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of pentylenetetrazol-induced seizures by hydralazine associated with 5-hydroxytryptaminergic system in rat brain.
    Hara S; Satoh T; Kitagawa H
    Jpn J Pharmacol; 1987 Apr; 43(4):361-8. PubMed ID: 2441099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of imipramine on the expression and development of morphine dependence in mice.
    Zarrindast MR; Torkaman-Boutorabi A
    Eur J Pharmacol; 2003 Jul; 473(1):19-25. PubMed ID: 12877933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentiation by TRH of the effect of imipramine on the forced-swimming test.
    Reny-Palasse V; Rips R
    Br J Pharmacol; 1985 Jun; 85(2):463-70. PubMed ID: 2992664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inversion of the alpha-2 and alpha-1 noradrenergic control of the cortical release of acetylcholine and gamma-aminobutyric acid in morphine-tolerant guinea pigs.
    Beani L; Bianchi C; Tanganelli S; Antonelli T; Simonato M; Rando S
    J Pharmacol Exp Ther; 1988 Oct; 247(1):294-301. PubMed ID: 2845056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of DL-erythro-dihydroxyphenylserine on the locomotor activity of the mouse.
    Mori T; Nakajima T; Hashimoto H; Noto T; Kato N
    Pharmacol Biochem Behav; 1985 Jun; 22(6):979-83. PubMed ID: 2862644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reserpine-resistant responses to nerve stimulation in the cat nictitating membrane involve the release of newly synthesized noradrenaline.
    Duval N; Hicks PE; Langer SZ
    Eur J Pharmacol; 1986 Mar; 122(1):93-101. PubMed ID: 2869963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the antinociceptive activities of physostigmine, oxotremorine and morphine in the mouse.
    Pleuvry BJ; Tobias MA
    Br J Pharmacol; 1971 Dec; 43(4):706-14. PubMed ID: 4261560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kainic acid-induced seizures: potentiation by alpha-methyl-p-tyrosine.
    Baran H; Hörtnagl H; Hornykiewicz O
    Brain Res; 1989 Aug; 495(2):253-60. PubMed ID: 2765930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of brain monoamines in the anticonvulsant effect of imipramine in albino rats.
    Bhattacharya SK; Mukhopadhyay SN; Reddy PK; Das PK
    Pharmacology; 1976; 14(5):428-34. PubMed ID: 199912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of p-chlorophenylalanine and alpha-methyltyrosine on the antinociceptive effect of antidepressant drugs.
    Sierralta F; Pinardi G; Miranda HF
    Pharmacol Toxicol; 1995 Oct; 77(4):276-80. PubMed ID: 8577640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha 2-adrenoceptors modulate kainic acid-induced limbic seizures.
    Baran H; Sperk G; Hörtnagl H; Sapetschnig G; Hornykiewicz O
    Eur J Pharmacol; 1985 Jul; 113(2):263-9. PubMed ID: 2995067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of central monoamine compounds on tranylcypromine-induced barbital-withdrawal convulsions.
    Tagashira E; Hiramori T; Nakao K; Urano T; Yanaura S
    Life Sci; 1983 Apr; 32(14):1599-606. PubMed ID: 6682167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of 3-methoxy-4-hydroxyphenylglycol (MHPG) in mouse brain by h.p.l.c. with electrochemical detection, as an index of noradrenaline utilisation and presynaptic alpha 2-adrenoceptor function.
    Heal DJ; Prow MR; Buckett WR
    Br J Pharmacol; 1989 Mar; 96(3):547-56. PubMed ID: 2541844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-Hydroxytryptamine-induced bronchoconstriction in the guinea-pig: effect of 5-HT2 receptor activation on acetylcholine release.
    Macquin-Mavier I; Jarreau PH; Istin N; Harf A
    Br J Pharmacol; 1991 Apr; 102(4):1003-7. PubMed ID: 1855111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan.
    de Boer TH; Nefkens F; van Helvoirt A; van Delft AM
    J Pharmacol Exp Ther; 1996 May; 277(2):852-60. PubMed ID: 8627567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of free MHPG in rat cerebrospinal fluid with free and conjugated MHPG in brain tissue: effects of drugs modifying noradrenergic transmission.
    Scheinin H; MacDonald E; Scheinin M
    Eur J Pharmacol; 1986 Sep; 129(1-2):113-21. PubMed ID: 2876902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.